-+ 0.00%
-+ 0.00%
-+ 0.00%

NextCell Pharma Presents Cell Therapy Manufacturing Strategy at BIO-Europe

PUBT·11/09/2026 12:05:29
Diffusion vocale
NextCell Pharma Presents Cell Therapy Manufacturing Strategy at BIO-Europe
  • NextCell Pharma will attend BIO-Europe 2026 in Cologne, Germany, November 9-11.
  • Chief Scientific Officer Lindsay Davies will present November 10 on moving allogeneic cell therapies from clinical development to commercial production.
  • Her presentation will draw on manufacturing experience from the NXTCL cell therapy platform.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. NextCell Pharma AB published the original content used to generate this news brief via Cision (Ref. ID: 202611090700BITN____UKPR__EN_20261109-BIT-6694-0) on November 09, 2026, and is solely responsible for the information contained therein.